openPR Logo
Press release

Oxipit's Chest X-ray Search Solution Selected as One of Top Innovations by SIIM

04-24-2018 01:09 PM CET | Health & Medicine

Press release from: Oxipit

Oxipit’s ChestGlass has been selected as one of the top projects for the 2018 Society for Imaging Informatics in Medicine (SIIM) Innovation Challenge. ChestGlass is the first-to-market chest X-ray search solution that allows to find radiologically similar images in a given database.

Vilnius, Lithuania – April 24, 2018 – Oxipit, a provider of medical image analysis software, today announced that their chest X-ray radiograph search solution ChestGlass has entered the 2018 Society for Imaging Informatics in Medicine (SIIM) Innovation Challenge semi-finals.

ChestGlass is a Deep Learning based image search solution which takes an unannotated image straight from the X-ray machine and uses the database of the hospital to find the most radiologically similar cases along with their reports. The ability to find similar cases within large databases assists the radiologist by making it easier to investigate radiographs with rare or difficult findings, as well as to carry out research. It will be especially useful for radiology residents and radiology professionals making a shift to another modality.

“Several decades ago chest X-ray technology has moved from photographic film to digital. By now, healthcare institutions have archived millions of images in databases which are virtually unused. Today, with excellent tools long available for general information search, radiology is ready for another step forward,” says Gediminas Peksys, CEO of Oxipit. “The novel possibility to query radiology databases not only by keywords or study IDs but also by full images will permanently alter the radiological workstation functionality expectations.”

While superficially similar to image search products in other industries, ChestGlass is custom tailored for radiological image search. It takes into account radiological findings and their localizations present in the image (pixel data only). In this way, ChestGlass seamlessly overcomes barriers of language and report structure diversity.

"This innovative solution has been made possible by cooperation between our clinical partners and the team of excellent data scientists at Oxipit. It is a pleasure to see their work widely appreciated," adds Mr. Peksys.

In addition to the chest X-ray radiograph search, Oxipit offers a spectrum of fully automatic solutions based on Deep Learning: chest X-ray computer-aided diagnosis (CAD); MRI brain anatomic segmentation, ischemic area and lesion detection/quantification; spine X-ray vertebrae segmentation and osteochondrosis/listhesis CAD.

Oxipit is currently looking for individual as well as institutional partners for pilot deployment and investigational use in the clinical environment. For more information, go to www.oxipit.ai.

MEDIA CONTACT

ABOUT OXIPIT (www.oxipit.ai)
Oxipit is a computer vision software startup specialized in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce recent Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice. Oxipit’s solutions bring value to radiologists (less routine tasks), healthcare institutions (more productive radiologists), and patients (more accurate diagnosis).

ABOUT SIIM (www.siim.org)
The Society for Imaging Informatics in Medicine (SIIM) represents more than 2000 healthcare professionals with interest in enterprise information and image management. SIIM is a not-for-profit organization focused on education, clinical practices, research, and innovation in the field of imaging informatics. The society is committed to actively contributing to the development and advancement of imaging informatics professionals and scientists worldwide and to improving the quality, safety, and efficiency of healthcare.

Oxipit, UAB
Sauletekio al. 15, 10224 Vilnius, Lithuania

Gediminas Peksys, CEO
info [at] oxipit.ai
+370 625 99148

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oxipit's Chest X-ray Search Solution Selected as One of Top Innovations by SIIM here

News-ID: 1027835 • Views:

More Releases from Oxipit

Oxipit Partners With CARPL To Increase Global Reach Of AI Diagnostic Products
03-02-2023 | Health & Medicine
Oxipit
Oxipit Partners With CARPL To Increase Global Reach Of AI Diagnostic Products
At the European Congress of Radiology in Vienna Oxipit announced that its diagnostic AI solutions will be available on the CARPL platform. CARPL platform users will have access to the full Oxipit AI product portfolio: ChestLink for healthy patient report automation, Quality - for real-time quality assurance and ChestEye - for preliminary reports. The move further builds on Oxipit strategy to increase global reach of company's products. "CARPL is our
Oxipit Secures Brazilian ANVISA Clearance for ChestEye AI Suite
02-15-2023 | Health & Medicine
Oxipit
Oxipit Secures Brazilian ANVISA Clearance for ChestEye AI Suite
The regulatory approval paves the way for ChestEye deployments in the Brazilian market. The application is already cleared for use in Europe and Australia. The Brazilian Health Regulatory Agency's approval is one of Oxipit steps to increase global reach for company products. "With many future-focused healthcare organizations, LatAm market shows tremendous potential for healthcare AI applications. Oxipit products have already shown strong market traction in the region. The ANVISA certification
Oxipit Closes $4.9M Funding Round To Advance AI Autonomy in Medical Imaging
01-23-2023 | Health & Medicine
Oxipit
Oxipit Closes $4.9M Funding Round To Advance AI Autonomy in Medical Imaging
AI medical imaging company Oxipit closed a $4.9M funding round led by Taiwania Capital and Practica Capital. Angel investors also participated in this round. The funding will help Oxipit advance its development of autonomous AI medical imaging applications and support market expansion into new geographic regions, with particular focus on the United Kingdom. "2022 was a breakthrough year for the Oxipit team. In spring we introduced ChestLink - the first fully
Oxipit Introduces Quality Assurance for MSK, MG, and CT Modalities
11-21-2022 | Health & Medicine
Oxipit
Oxipit Introduces Quality Assurance for MSK, MG, and CT Modalities
AI medical imaging company Oxipit expanded its Quality product suite with quality assurance support for musculoskeletal X-rays, mammography images and lung CT scans. Previously supporting only chest X-rays, the upgraded Quality suite aims to answer all imaging department quality assurance needs with a single product. The updated Quality product will be showcased at RSNA 2022 annual meeting later this month. Oxipit Quality employs AI as the second reader for quality assurance.

All 5 Releases